178

Immunology & Rheumatology
Focuses on rheumatic and immune diseases.
Sub Categories on Immunology & Rheumatology
Latest Articles
Study suggests parents' understanding of atopic dermatitis may influence child's diet

Study suggests parents' understanding of atopic dermatitis may influence child's diet

byAmerican College of Allergy, Asthma, and ImmunologyCredit: CC0 Public DomainParents of children with atopic dermatitis (AD, also called eczema) know that the allergic condition can mean a heig

Study suggests parents' understanding of atopic dermatitis may influence child's diet

byAmerican College of Allergy, Asthma, and ImmunologyCredit: CC0 Public DomainParents of children with atopic dermatitis (AD, also called eczema) know that the allergic condition can mean a heig
A stealthy way to combat tumors

A stealthy way to combat tumors

by Anne Trafton,Massachusetts Institute of TechnologyMIT researchers have identified a specialized subset of dendritic cells that help stimulate T cells to attack tumors. In this image, the blue

A stealthy way to combat tumors

by Anne Trafton,Massachusetts Institute of TechnologyMIT researchers have identified a specialized subset of dendritic cells that help stimulate T cells to attack tumors. In this image, the blue
Here's why B cells benefit from booster shots

Here's why B cells benefit from booster shots

byRockefeller UniversityRecall germinal centers formed in response to a secondary infection generate a second line of defense, rebuffing memory B cells in favor of training naive ones. Credit: R

Here's why B cells benefit from booster shots

byRockefeller UniversityRecall germinal centers formed in response to a secondary infection generate a second line of defense, rebuffing memory B cells in favor of training naive ones. Credit: R
Gout is primary indication in about 0.2 percent of ER visits

Gout is primary indication in about 0.2 percent of ER visits

Gout is the primary indication in about 0.2 percent of emergency department visits annually, according to a study published online Sept. 4 inArthritis Care & Research.(HealthDay)—Gout is the

Gout is primary indication in about 0.2 percent of ER visits

Gout is the primary indication in about 0.2 percent of emergency department visits annually, according to a study published online Sept. 4 inArthritis Care & Research.(HealthDay)—Gout is the
An antibody-drug combo to combat cancer

An antibody-drug combo to combat cancer

by Tokyo Medical and Dental UniversityCredit: Tokyo Medical and Dental UniversityLeukemias are debilitating cancers of the hematopoietic or blood-forming cells of the bone marrow. Now, researchers at

An antibody-drug combo to combat cancer

by Tokyo Medical and Dental UniversityCredit: Tokyo Medical and Dental UniversityLeukemias are debilitating cancers of the hematopoietic or blood-forming cells of the bone marrow. Now, researchers at
Gene variant exacerbates inflammatory arthritis in mice

Gene variant exacerbates inflammatory arthritis in mice

by University of Utah Health SciencesA swollen ankle joint with severe inflammatory arthritis. A build up of glycosaminoglycans (GAGs), long carbohydrate chains, is thought to contribute to sever

Gene variant exacerbates inflammatory arthritis in mice

by University of Utah Health SciencesA swollen ankle joint with severe inflammatory arthritis. A build up of glycosaminoglycans (GAGs), long carbohydrate chains, is thought to contribute to sever
Scientists discover two cellular defects appear to drive disease in lupus

Scientists discover two cellular defects appear to drive disease in lupus

byNorthwestern UniversityCredit: Pixabay/CC0 Public DomainNorthwestern Medicine and Brigham and Women's Hospital scientists have discovered a molecular defect that promotes the pathologic im

Scientists discover two cellular defects appear to drive disease in lupus

byNorthwestern UniversityCredit: Pixabay/CC0 Public DomainNorthwestern Medicine and Brigham and Women's Hospital scientists have discovered a molecular defect that promotes the pathologic im
How one patient's rare mutation helped solve a mycobacterial mystery

How one patient's rare mutation helped solve a mycobacterial mystery

by Katherine Fenz,Rockefeller UniversityGraphical Abstract. Credit:Cell(2020). DOI: 10.1016/j.cell.2020.10.046Just because you are exposed to a pathogen does not mean you will become

How one patient's rare mutation helped solve a mycobacterial mystery

by Katherine Fenz,Rockefeller UniversityGraphical Abstract. Credit:Cell(2020). DOI: 10.1016/j.cell.2020.10.046Just because you are exposed to a pathogen does not mean you will become
Sleep problems not a major issue in rheumatoid arthritis

Sleep problems not a major issue in rheumatoid arthritis

Sleep problems are not excessive in patients with newly diagnosed rheumatoid arthritis, according to a study recently published inRMD Open.Lauren Lyne, from the Karolinska Institutet in Stockhol

Sleep problems not a major issue in rheumatoid arthritis

Sleep problems are not excessive in patients with newly diagnosed rheumatoid arthritis, according to a study recently published inRMD Open.Lauren Lyne, from the Karolinska Institutet in Stockhol
T cells: Vesicles strengthen immune response

T cells: Vesicles strengthen immune response

by Ludwig Maximilian University of MunichMFG-E8-eGFP detects PS+ apoptotic and PS+ EV-decorated cells in vivo. Credit: Proceedings of the National Academy of Sciences (2023). DOI: 10.1073/pnas.22

T cells: Vesicles strengthen immune response

by Ludwig Maximilian University of MunichMFG-E8-eGFP detects PS+ apoptotic and PS+ EV-decorated cells in vivo. Credit: Proceedings of the National Academy of Sciences (2023). DOI: 10.1073/pnas.22
FDA approves first interchangeable biosimilar for inflammatory diseases

FDA approves first interchangeable biosimilar for inflammatory diseases

(HealthDay)—The first interchangeable biosimilar product to Humira (adalimumab) was approved by the U.S. Food and Drug Administration on Oct. 15, the agency announced Monday.Cyltezo (adalimumab-adbm),

FDA approves first interchangeable biosimilar for inflammatory diseases

(HealthDay)—The first interchangeable biosimilar product to Humira (adalimumab) was approved by the U.S. Food and Drug Administration on Oct. 15, the agency announced Monday.Cyltezo (adalimumab-adbm),
Among allergic conditions, food allergy found to have highest risk of developing eosinophilic esophagitis

Among allergic conditions, food allergy found to have highest risk of developing eosinophilic esophagitis

byAmerican College of Allergy, Asthma, and ImmunologyCredit: Unsplash/CC0 Public DomainEosinophilic esophagitis (EoE), a disorder of the esophagus, is increasingly recognized as a major cause of

Among allergic conditions, food allergy found to have highest risk of developing eosinophilic esophagitis

byAmerican College of Allergy, Asthma, and ImmunologyCredit: Unsplash/CC0 Public DomainEosinophilic esophagitis (EoE), a disorder of the esophagus, is increasingly recognized as a major cause of